(Q46861788)

25 December 2017

title

DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells (English)

1 reference

25 December 2017

1 reference

1 reference

Hanh Le

1

1 reference

25 December 2017

Julia T Arnold

series ordinal

2

1 reference

25 December 2017

Kimberly K McFann

series ordinal

3

1 reference

25 December 2017

Marc R Blackman

series ordinal

4

1 reference

25 December 2017

publication date

20 December 2005

1 reference

25 December 2017

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

25 December 2017

volume

290

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

E952-60

1 reference

25 December 2017

Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Characterization of 5alpha-reductase gene expression in stroma and epithelium of human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Role of stroma in carcinogenesis of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Androgen regulation of the rat keratinocyte growth factor (KGF/FGF7) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Cellular actions of the insulin-like growth factor binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Prospective study of sex hormone levels and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Induction of 3beta-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Androgen receptor signaling in androgen-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Testosterone- and phorbol ester-stimulated proliferation in human cultured prostatic stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Adrenal steroids in human prostatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Fibroblast growth factor-10. A second candidate stromal to epithelial cell andromedin in prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Risk factors for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Insulin-like growth factor physiology and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Androgen Receptor Antagonist versus Agonist Activities of the Fungicide Vinclozolin Relative to Hydroxyflutamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Growth factors and epithelial-stromal interactions in prostate cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00451.2005

10.1152/AJPENDO.00451.2005

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017